Drug Vial Size Report

 

The purpose of the program is to conduct a study that highlights Federal healthcare costs, safety and quality concerns associated with discarded drugs that result from disproportionate vial sizes.

Deleted 03/27/2024 (Archived.) 93.685 Centers For Medicare and Medicaid Services, Department of Health and Human Services A - Formula Grants Not applicable. Public Law Senate Report-114-274
CMS shall enter into an agreement with the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine [the Academies] to conduct a study on the Federal healthcare costs, safety, and quality concerns associated with discarded drugs that results from weight-based dosing of medicines contained in single dose vials as stated in Senate report 114–274. The Committee recommendation includes $1,200,000 of the resources provided in Program Operations for this activity and CMS is directed to provide an update to the Committee’s on Appropriations 15 days after the enactment of this act and every 90 days thereafter until the report is completed. CMS and the Academies are encouraged to consult with FDA. State, Local, Unemployed, Welfare Recipient, Sponsored organization, Low Income, Public nonprofit institution/organization, Other public institution/organization, Federally Recognized Indian Tribal Governments State, Intrastate, Local, Sponsored Organization, Public Nonprofit Institution/Organization, Other Public Institution/organization, Federally Recognized Indian Tribal Government, U.S. territory/possession, individual/family Not applicable. Not applicable. Preapplication coordination is required. N/A 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. All instructions covered by 2 CFR 200 If successful, Applicant will receive a Notice of Award (NoA) signed and dated by the HHS Grants Management Officer. The NoA is the document authorizing the grant award and will be issued to the applicant as listed on the SF-424 and available to the organization through the online grants management system used by CMS and awardee organizations. Any communication between HHS and Applicant prior to issuance of the NoA is not an authorization to begin performance of a project. If unsuccessful, Applicant will be notified by letter, sent electronically or through the U.S. Postal Service to the address as listed on its SF-424, within 30 days of the award date. Contact the headquarters or regional location, as appropriate for application deadlines Approximately 30-45 days Not applicable. Not applicable. Not applicable. Funds will be available for services related to a study on the Federal healthcare costs, safety, and quality concerns associated with discarded drugs that results from weight-based dosing of medicines contained in single dose vials as stated in Senate report 114–274. Performance Reports: Quarterly progress reports will be used to monitor performance. Not applicable. Daily attendance records, personnel records, property and equipment records. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Twelve months (1 year) from the date of award with 12 month budget period. Method of awarding/releasing assistance: quarterly Method of awarding/releasing assistance: Quarterly. CMS Main Headquarters 7500 Security Boulevard Baltimore, MD 21244 Alisha Williams
7500 Security Boulevard
Baltimore, MD 21244 US
alisha.williams@cms.hhs.gov
Phone: 410-786-7507
Fax: 410-786-7667

Deborah Pujals Keyser
7500 Security Blvd.
Baltimore, MD 21244 USA
Deborah.pujalskeyser@cms.hhs.gov
Phone: 410-786-8096
Fax: 410-786-7667 http://www.cms.gov 75-0511-0-1-551 (Formula Grants (Cooperative Agreements)) FY 18 FY 19 est $1,200,000.00; FY 20 - N/A Not applicable. Not applicable.